---
title: Porton Advanced vs Minaris Advanced Therapies
slug_a: porton-advanced
slug_b: wuxi-advanced-therapies
site: cdmo
review_signal_gate: closed
canonical_path: /compare/porton-advanced/wuxi-advanced-therapies
---

# Porton Advanced vs Minaris Advanced Therapies

Side-by-side profile data from each company listing on this directory.

## Porton Advanced

- Profile: [/companies/porton-advanced](/companies/porton-advanced)

Porton Advanced — End-to-end ATMP CDMO provider offering cell engineering, lentiviral vectors, mRNA/LNP, plasmid development, and GMP manufacturing from preclinical through commercialization with 24 IND approvals across NMPA, FDA, and MedSafe.

Services: 14. Modalities: 4. Indications: 0. Locations: 18. Certifications: 0. The strongest documented coverage currently appears in locations (18).

### Services

- Cell-Line Development
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- mRNA Manufacturing
- Lipid Nanoparticle (LNP) Formulation
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- mRNA
- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Cell-Free

## Minaris Advanced Therapies

- Profile: [/companies/wuxi-advanced-therapies](/companies/wuxi-advanced-therapies)

Minaris Advanced Therapies — Pure-play cell and gene therapy CDMO with over 25 years of GMP manufacturing, process development, and biosafety testing expertise. Serves advanced therapy innovators globally from early stage through commercialization.

Services: 15. Modalities: 6. Indications: 0. Locations: 14. Certifications: 6. The strongest documented coverage currently appears in services (15).

### Services

- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Vaccine Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Vaccine
- AAV / Viral Vector Platform

### Development capabilities

- Analytical method development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Viral Vector